Patients who have undergone organ transplantation have an elevated risk of infection from viruses such as CMV, which is a common virus that infects people of all ages. Once CMV is in a person’s body, it stays there for life in latent form and can reactivate. Among organ transplant patients, an estimated 40–70% of post-transplant mortality is linked to higher susceptibility to opportunistic infections, frequently caused by viruses. Timely and accurate monitoring of viral load through a molecular test is essential for these patients, especially for those patients undergoing antiviral drug therapy for a viral infection.
We provide molecular tests, such as a CMV test, for CMV post transplant testing and viral load monitoring.